jsr

JSR to Complete 115B Yen Transfer of Elastomers Business to Eneos in April 2022

Leading synthetic rubber manufacturer JSR Corp. (TYO:4185) has announced plans to transfer its elastomers business to Eneos Corp. Due to be completed on April 1, 2022, the deal here will be based on a valuation of 115 billion yen ($1.05 billion). Commenting on the deal, JSR CEO Eric Johnson acknowledged that elastomers have been a core business for JSR since...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

JSR Anticipates 5% Revenue Growth From Elastomers for 2021

JSR Corp. (TYO:4185) has announced its earnings forecast for fiscal 2021. The synthetic rubber manufacturer projects that it will be able to generate 468 billion yen ($4.28 billion) in sales revenue, up 4.8 percent year-on-year; 53 billion yen in core operating profit, up 104.1 percent; and 32 billion yen in net profit, a major turnaround from the 55.2 billion yen...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

JSR Targets Record Profit for Fiscal 2024 as Part of Medium-Term Strategy

JSR Corp. (TYO:4185) is looking to set a new record high profit in fiscal 2024 as part of its latest medium-term management policy, which lays out plans and targets through to that same year. On the topic of JSR’s future business portfolio, the new management policy looks to position digital solutions – especially for semiconductors – and life sciences as...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

JSR to Seek Early Retirement by Elastomers Workers 40 and Over With Three-Plus Years’ Employment

JSR Corp. (TYO:4185) plans to solicit early retirement among about 100 employees in its elastomers business. Seeking to make the change to a more robust business structure, JSR is optimizing its production capacity and product portfolio, rationalizing prices and working to bring about major improvements in its operating efficiency. The company is also implementing unlimited structural reforms throughout its organization,...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

JSR Subsidiary Makes Investment Into Biopharmaceutical Production

JSR Life Sciences LLC, a group company under JSR Corp. (TYO:4185), recently announced that it will be expanding cutting-edge facilities in Europe to grow its business for biopharmaceuticals. These facilities will serve to bolster the activities of two affiliates: namely, U.S.-based KBI Biopharma Inc. and Swiss-based Selexis SA. Through this expansion, the two affiliates will end up occupying a combined...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

JSR Starts Shipments of S-SBR Produced at Hungarian Plant

JSR Corp. (TYO:4185) has started to ship out solution-polymerized styrene–butadiene rubber (S-SBR) manufactured at JSR MOL Synthetic Rubber Ltd. The shipment launch was announced on Oct. 27 by JSR Director and Managing Officer Hideki Miyazaki, who gave the news during an online briefing regarding the company’s financial results for the second quarter of fiscal 2020. Miyazaki said that while it...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading